Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Not Applicable

Recruiting

• Conditions: Cancer

• Registration Number: NCT06851975
• Lead Sponsor: Centre Antoine Lacassagne

Brief Summary

Research into biomarkers predictive of survival and response to cancer treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-07
• Status Verified: 2025-02
• Study First Submitted: 2025-02-14
• Study First Submitted QC: 2025-02-24
• Last Update Submitted: 2025-02-24
• Study First Posted: 2025-02-28
• Last Update Posted: 2025-02-28
• Primary Completion: 2099-12-31
• Study Completion: 2099-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 40000

Inclusion Criteria

• Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
• Patient who has read the information note and stated that he/she has no objections
• Patient who has not objected to the use of this data for medical research purposes
• Patient with social security cover.

Exclusion Criteria

• Patient already included in the study
• Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Prediction	day 1	The aim of this project is to make a biobank in prevision of MR004 sub-projects which define specific biomarkers studied to identify biomarkers predictive of response.

Trial Locations

Locations (1)

Centre Antoine Lacassagne; 🇫🇷 Nice, France